Bivalent mRNA vaccine booster induces robust antibody immunity against Omicron lineages BA.2, BA.2.12.1, BA.2.75 and BA.5
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2056-5968
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Bivalent mRNA vaccine booster induces robust antibody immunity against Omicron lineages BA.2, BA.2.12.1, BA.2.75 and BA.5 ; volume:8 ; number:1 ; day:11 ; month:10 ; year:2022 ; pages:1-4 ; date:12.2022
Cell discovery ; 8, Heft 1 (11.10.2022), 1-4, 12.2022
- Urheber
-
Fang, Zhenhao
Monteiro, Valter S.
Hahn, Anne M.
Grubaugh, Nathan D.
Lucas, Carolina
Chen, Sidi
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41421-022-00473-4
- URN
-
urn:nbn:de:101:1-2022122821170882095172
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 15.08.2025, 05:25 UTC
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Fang, Zhenhao
- Monteiro, Valter S.
- Hahn, Anne M.
- Grubaugh, Nathan D.
- Lucas, Carolina
- Chen, Sidi
- SpringerLink (Online service)
Ähnliche Objekte (12)
Bivalent COVID-19 mRNA booster vaccination (BA.1 or BA.4/BA.5) increases neutralization of matched Omicron variants
Three-month antibody persistence of a bivalent Omicron-containing booster vaccine against COVID-19
Effectiveness of mRNA COVID-19 vaccine booster doses against Omicron severe outcomes
Enhancement of Omicron-specific immune responses following bivalent COVID-19 booster vaccination in patients with chronic lymphocytic leukaemia
Neutralization of Omicron XBB.1 by booster vaccination with BA.4/5 monovalent mRNA vaccine
mRNA booster vaccination protects aged mice against the SARS-CoV-2 Omicron variant
Heterologous mRNA vaccine booster increases neutralization of SARS-CoV-2 Omicron BA.2 variant
Author Correction: Effectiveness of mRNA COVID-19 vaccine booster doses against Omicron severe outcomes
Omicron-specific mRNA vaccination alone and as a heterologous booster against SARS-CoV-2
A booster dose of Delta × Omicron hybrid mRNA vaccine produced broadly neutralizing antibody against Omicron and other SARS-CoV-2 variants
Omicron-specific and bivalent omicron-containing vaccine candidates elicit potent virus neutralisation in the animal model
mRNA-1273 bivalent (original and Omicron) COVID-19 vaccine effectiveness against COVID-19 outcomes in the United States
Bivalent COVID-19 mRNA booster vaccination (BA.1 or BA.4/BA.5) increases neutralization of matched Omicron variants
Three-month antibody persistence of a bivalent Omicron-containing booster vaccine against COVID-19
Effectiveness of mRNA COVID-19 vaccine booster doses against Omicron severe outcomes
Enhancement of Omicron-specific immune responses following bivalent COVID-19 booster vaccination in patients with chronic lymphocytic leukaemia
Neutralization of Omicron XBB.1 by booster vaccination with BA.4/5 monovalent mRNA vaccine
mRNA booster vaccination protects aged mice against the SARS-CoV-2 Omicron variant
Heterologous mRNA vaccine booster increases neutralization of SARS-CoV-2 Omicron BA.2 variant
Author Correction: Effectiveness of mRNA COVID-19 vaccine booster doses against Omicron severe outcomes
Omicron-specific mRNA vaccination alone and as a heterologous booster against SARS-CoV-2
A booster dose of Delta × Omicron hybrid mRNA vaccine produced broadly neutralizing antibody against Omicron and other SARS-CoV-2 variants
Omicron-specific and bivalent omicron-containing vaccine candidates elicit potent virus neutralisation in the animal model
mRNA-1273 bivalent (original and Omicron) COVID-19 vaccine effectiveness against COVID-19 outcomes in the United States
Bivalent COVID-19 mRNA booster vaccination (BA.1 or BA.4/BA.5) increases neutralization of matched Omicron variants
Three-month antibody persistence of a bivalent Omicron-containing booster vaccine against COVID-19
Effectiveness of mRNA COVID-19 vaccine booster doses against Omicron severe outcomes
Enhancement of Omicron-specific immune responses following bivalent COVID-19 booster vaccination in patients with chronic lymphocytic leukaemia
Neutralization of Omicron XBB.1 by booster vaccination with BA.4/5 monovalent mRNA vaccine
mRNA booster vaccination protects aged mice against the SARS-CoV-2 Omicron variant
Heterologous mRNA vaccine booster increases neutralization of SARS-CoV-2 Omicron BA.2 variant
Author Correction: Effectiveness of mRNA COVID-19 vaccine booster doses against Omicron severe outcomes
Omicron-specific mRNA vaccination alone and as a heterologous booster against SARS-CoV-2
A booster dose of Delta × Omicron hybrid mRNA vaccine produced broadly neutralizing antibody against Omicron and other SARS-CoV-2 variants
Omicron-specific and bivalent omicron-containing vaccine candidates elicit potent virus neutralisation in the animal model